We are live on ! Find out more
MXCT icon

MaxCyte
MXCT

120 hedge funds and large institutions have $268M invested in MaxCyte in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 51 increasing their positions, 30 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

70% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 30

5% more funds holding

Funds holding: 114 → 120 (+6)

0.04% more ownership

Funds ownership: 65.37% → 65.4% (+0.04%)

0% less capital invested

Capital invested by funds: $269M → $268M (-$582K)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

56% less call options, than puts

Call options by funds: $4K | Put options by funds: $9K

Holders
120
Holders Change
+6
Holders Change %
+5.26%
% of All Funds
1.72%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
12
Increased
51
Reduced
30
Closed
6
Calls
$4K
Puts
$9K
Net Calls
-$5K
Net Calls Change
+$1K

Top Buyers

1
CP
CenterBook Partners
Connecticut
+$2.47M
2
CCM
Cadian Capital Management
New York
+$2.38M
3
SAM
Silvercrest Asset Management
New York
+$1.62M
4
BlackRock
BlackRock
New York
+$1.46M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$959K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$4.15M
2
BWLSA
Blue Water Life Science Advisors
California
-$2.37M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$1.96M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.84M
5
PCM
Portolan Capital Management
Massachusetts
-$1.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
Lazard Asset Management
26
Lazard Asset Management
New York
$1.41M -$217K -51,448 -12%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.34M -$327K -77,603 -18%
RA
28
Royce & Associates
New York
$1.26M +$511K +121,272 +60%
AMH
29
Apollo Management Holdings
New York
$1.2M – – –
Charles Schwab
30
Charles Schwab
California
$1.17M +$3.21K +761 +0.3%
William Blair & Company
31
William Blair & Company
Illinois
$1.06M +$11.3K +2,690 +1%
RG
32
Rathbones Group
United Kingdom
$995K -$40.6K -9,634 -4%
BL
33
Bleichroeder LP
New York
$980K – – –
Marshall Wace
34
Marshall Wace
United Kingdom
$866K -$1.17M -277,075 -55%
UBS AM
35
UBS AM
Illinois
$792K -$114K -27,111 -12%
Bank of America
36
Bank of America
North Carolina
$767K +$180K +42,802 +28%
JP Morgan Chase
37
JP Morgan Chase
New York
$755K -$65.6K -15,573 -7%
Renaissance Technologies
38
Renaissance Technologies
New York
$739K -$87.7K -20,814 -10%
Swiss National Bank
39
Swiss National Bank
Switzerland
$717K – – –
Barclays
40
Barclays
United Kingdom
$645K +$536K +127,156 +329%
Bank of Montreal
41
Bank of Montreal
Ontario, Canada
$635K – – –
American Century Companies
42
American Century Companies
Missouri
$628K +$73.4K +17,432 +12%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$588K -$26.8K -6,363 -4%
Squarepoint
44
Squarepoint
New York
$559K -$725 -172 -0.1%
Citigroup
45
Citigroup
New York
$506K +$206K +48,913 +61%
SO
46
STRS Ohio
Ohio
$468K – – –
M&T Bank
47
M&T Bank
New York
$443K +$108K +25,644 +29%
VA
48
Valmark Advisers
Ohio
$440K -$1.44K -342 -0.3%
Legal & General Group
49
Legal & General Group
United Kingdom
$392K +$16.3K +3,877 +4%
US Bancorp
50
US Bancorp
Minnesota
$370K -$4.32K -1,025 -1%
1
2
3 4 5

MXCT Hedge Fund Activity: Q3 2024 in Review

120 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q3 2024, worth a combined $268M — down 0.22% from $269M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new MXCT positions and 6 closed out — a net gain of 6 holders — while 51 added to existing stakes and 30 trimmed.

The largest buyer was CenterBook Partners, opening a new position worth an estimated $2.47M. The largest seller was Millennium Management, cutting an estimated $4.15M.

  • 120 institutional investors held MaxCyte (MXCT) as of Q3 2024, up from 114 in Q2 2024.
  • Funds reported $268M of MaxCyte stock for Q3 2024, down 0.22% quarter-over-quarter.
  • 12 funds opened new MaxCyte positions in Q3 2024 and 6 closed out, a net change of +6 holders.
  • The largest MaxCyte buyer in Q3 2024 was CenterBook Partners, an estimated $2.47M added.
  • The largest MaxCyte seller in Q3 2024 was Millennium Management, an estimated $4.15M sold.

Based on aggregated 13F filings for Q3 2024.